MBX-4132 is primarily utilized in the field of medical research, particularly in the study of metabolic disorders. It serves as a potent and selective inhibitor of certain enzymes that play a critical role in lipid metabolism. Researchers employ this compound to investigate the pathways and mechanisms involved in diseases such as obesity, diabetes, and non-alcoholic fatty liver disease. By inhibiting specific targets, MBX-4132 helps in understanding the biochemical processes that contribute to these conditions, paving the way for the development of potential therapeutic interventions. Additionally, it is used in preclinical studies to assess the efficacy and safety of new drugs aimed at modulating metabolic pathways. Its application is crucial in advancing knowledge and treatment strategies for complex metabolic syndromes.